28
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Comparison of a Long-Acting LHRH Agonist and Polyoestradiol Phosphate in the Treatment of Advanced Prostatic Carcinoma

An Open Prospective, Randomized Multicentre Study

, &
Pages 171-178 | Received 19 Feb 1993, Accepted 08 Jun 1993, Published online: 15 Feb 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Rafal Turo, Michal Smolski, Rachel Esler, Magda L. Kujawa, Stephen J. Bromage, Neil Oakley, Adebanji Adeyoju, Stephen C. W. Brown, Richard Brough, Andrew Sinclair & Gerald N. Collins. (2014) Diethylstilboestrol for the treatment of prostate cancer: past, present and future. Scandinavian Journal of Urology 48:1, pages 4-14.
Read now
Paul de Souza & Fred Saad. (2011) Bone health in prostate cancer. Expert Review of Endocrinology & Metabolism 6:3, pages 317-321.
Read now
Per Olov Hedlund, Jan-Erik Damber, Inger Hagerman, Svein Haukaas, Peter Henriksson, Peter Iversen, Robert Johansson, Peter Klarskov, Finn Lundbeck, Finn Rasmussen, Eberhard Varenhorst, Jouko Viitanen, Per Olov Hedlund, Jan-Erik Damber, Inger Hagerman, Svein Haukaas, Peter Henriksson, Peter Iversen, Robert Johansson, Peter Klarskov, Finn Lundbeck, Finn Rasmussen, Eberhard Varenhorst & Jouko Viitanen. (2008) Parenteral estrogen versus combined androgen deprivation in the treatment of metastatic prostatic cancer: Part 2. Final evaluation of the Scandinavian Prostatic Cancer Group (SPCG) Study No. 5. Scandinavian Journal of Urology and Nephrology 42:3, pages 220-229.
Read now

Articles from other publishers (11)

Ankur Bahl, Senthil Rajappa, Sudhir Rawal, Ganesh Bakshi, Vedang Murthy & Ketaki Patil. (2022) A review of clinical evidence to assess differences in efficacy and safety of luteinizing hormone–releasing hormone (LHRH) agonist (goserelin) and LHRH antagonist (degarelix). Indian Journal of Cancer 59:5, pages 160.
Crossref
Lucie-Marie Scailteux, Florian Naudet, Quentin Alimi, Sébastien Vincendeau & Emmanuel Oger. (2016) Mortality, cardiovascular risk, and androgen deprivation therapy for prostate cancer. Medicine 95:24, pages e3873.
Crossref
Charlotte E. Almasi, Klaus Brasso, Peter Iversen, Helle Pappot, Gunilla Høyer‐Hansen, Keld Danø & Ib J. Christensen. (2010) Prognostic and predictive value of intact and cleaved forms of the urokinase plasminogen activator receptor in metastatic prostate cancer. The Prostate 71:8, pages 899-907.
Crossref
G Norman, M E Dean, R E Langley, Z C Hodges, G Ritchie, M K B Parmar, M R Sydes, P Abel & A J Eastwood. (2008) Parenteral oestrogen in the treatment of prostate cancer: a systematic review. British Journal of Cancer 98:4, pages 697-707.
Crossref
Jeremy Ockrim, El-Nasir Lalani & Paul Abel. (2006) Therapy Insight: parenteral estrogen treatment for prostate cancer—a new dawn for an old therapy. Nature Clinical Practice Oncology 3:10, pages 552-563.
Crossref
ANNA-CLARA SPETZ, MATS HAMMAR, BENGT LINDBERG, ANDERS SPÅNGBERG & EBERHARD VARENHORST. (2001) PROSPECTIVE EVALUATION OF HOT FLASHES DURING TREATMENT WITH PARENTERAL ESTROGEN OR COMPLETE ANDROGEN ABLATION FOR METASTATIC CARCINOMA OF THE PROSTATE. Journal of Urology 166:2, pages 517-520.
Crossref
Per Olov Hedlund. (2000) Side effects of endocrine treatment and their mechanisms: Castration, antiandrogens, and estrogens. The Prostate 45:S10, pages 32-37.
Crossref
J. E. Altwein, M. Wirth, H. Rübben & T. Otto. 1998. Prostatakarzinom — Pathologie, Praxis und Klinik. Prostatakarzinom — Pathologie, Praxis und Klinik 63 165 .
Arnon KrongradSilvina LevisBernard A. Roos. (1997) RE: OSTEOPOROSIS AFTER ORCHIECTOMY FOR PROSTATE CANCER. Journal of Urology 158:4, pages 1529-1530.
Crossref
J. E. Altwein. 1997. Uroonkologie. Uroonkologie 233 399 .
R. Lee CoxE. David Crawford. (1995) Estrogens in the Treatment of Prostate Cancer. Journal of Urology 154:6, pages 1991-1998.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.